Breaking Finance News

Evonik Industries (ETR:EVK) stock price target raised to 30.00EUR, reported today by Baader Wertpapierhandelsbank

Just yesterday Evonik Industries (ETR:EVK) traded 4.35% higher at 29.53EUR. EVK’s 50-day average is 2.32EUR and its two hundred day average is 2.10EUR. With the last stock price close up 14.08% relative to the two hundred day average, compared with the S&P 500 Index which has decreased -0.01% over the same period. Volume of trade was down over the average, with 500 shares of EVK changing hands under the typical 6,902

Evonik Industries (ETR:EVK) had its target price raised to 30.00EUR by Baader Wertpapierhandelsbank in a report issued 10/14/2016. The updated stock price target implies a possible upside of 0.02% based on the company's previous stock price.

Performance Chart

Evonik Industries (ETR:EVK)

Evonik Industries has a 52 week low of 1.35EUR and a 52 week high of 3.09EUR with a P/E ratio of 3.44 The company’s market cap is currently 0 EUR.

Brief Synopsis About Evonik Industries (ETR:EVK)

Evonik Industries AG (Evonik) is a Germany-based company engaged in the specialty chemicals sector. The Company's activities are divided in four segments: Nutrition & Care, produces specialty chemicals, mainly for use in consumer goods for daily needs and food, as well as in animal nutrition and healthcare products; Resource Efficiency, offers material solutions for environment-friendly and energy-efficient products used in the automotive, adhesives and construction industries, among others; Performance Materials, produces polymer materials and their intermediates, mainly for the rubber, plastics and agriculture sectors, and Services, includes site management, utilities and waste management, as well as technical, process technology, engineering and logistics services for the chemicals segments and external customers at Company's sites, among others. It is a subsidiary of RAG Stiftung.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.

Leave a Reply

Your email address will not be published. Required fields are marked *